Explore › Intervention › History of
Intervention

History of

Also known as: History History of History of (contextual qualifier) History of (contextual qualifier) (qualifier value) History of preeclampsia/eclampsia/preeclampsia superimposed on chronic hypertension (severe HDP subtypes during 1976-1982 pregnancies)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
Syphilitic coronary artery disease1
outcomes
Coronary Artery Disease1
populations
Pregnant Women1
studys
PMC72130621

Findings (27)

None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →

Papers (1)